The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives.
Progestin-only contraceptives are associated with menstrual bleeding disturbances; a major reason why these agents are discontinued. The pathogenesis of abnormal uterine bleeding associated with progestin-only contraceptives remains ill-defined. Matrix metalloproteinases (MMPs) and leukocytes are postulated to be involved in the process of normal menstruation. Immunolocalization of MMPs and leukocytes in (Norplant), and injectable depot medroxyprogesendometrium from women using the progestinterone acetate (DMPA), are widely used, safe and only contraceptives, Norplant or depot medroxyprogesterone acetate (DMPA) compared with normal controls, revealed foci of positive MMP-1 and -3 immunostaining in stromal cells and adjacent extracellular matrix, the presence of MMP-9 in various subtypes of leukocytes and alterations in mast cell phenotype. In women using progestin-only contraceptives, extent of endometrial MMP, neutrophil and eosinophil immunolocalization and the mast cell activation state was similar to or greater than that observed in perimenstrual control women. However, differences in MMP immunostaining were observed in endometrial samples from women using different progestin-only contraceptive agents; in particular, significantly higher MMP-1 immunostaining was observed associated with the use of Norplant compared with DMPA. No correlation was observed with the number of bleeding days recorded. These results suggest that MMP and leukocytes may be involved in endometrial breakdown in women using progestin-only contraceptives.
Vincent
A J
AJ
Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia.
Salamonsen
L A
LA
D001706:Biopsy; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D004717:Endometrium / Q000201:enzymology / Q000473:pathology; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000502:physiology*; D016912:Levonorgestrel / Q000009:adverse effects; D020782:Matrix Metalloproteinases / Q000032:analysis / Q000502:physiology*; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects*; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000201:enzymology / Q000473:pathology
D003271:Contraceptive Agents, Female; D011372:Progestins; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate; D020782:Matrix Metalloproteinases